SCHEMBL31682957

CC(=O)N[C@@H]1[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4NC(C)=O)[C@H]3O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H](CO)O[C@@H]1O

nearest known ligand 0.52

Predicted protein targets (top 15)

	gene	UniProt	supporting neighbours	confidence
▸	MAPK1	P28482	2/20	0.52

▸	LGALS3	P17931	5/20	0.51

▸	LGALS8	O00214	1/20	0.51

▸	LGALS4	P56470	1/20	0.51

▸	CD69	Q07108	1/20	0.48

▸	CHIA	Q9BZP6	1/20	0.48

▸	ALDH1A1	P00352	1/20	0.45

▸	THRB	P10828	1/20	0.45

▸	MDK	P21741	2/20	0.43

▸	PTN	P21246	1/20	0.43

▸	BDNF	P23560	1/20	0.43

▸	LGALS1	P09382	1/20	0.42

▸	LGALS7; LGALS7B	P47929	1/20	0.42

▸	CD209	Q9NNX6	1/20	0.41

▸	AMY2A	P04746	1/20	0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31682928	0.95	MAPK1 (0.53)	MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL29407987	0.90	LGALS3 (0.60)	MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL31682931	0.89	MAPK1 (0.54)	MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL24484198	0.88	MDK (0.53)	MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL22071113	0.88	MDK (0.53)	MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL6748051	0.88	MDK (0.53)	MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL932879	0.88	MDK (0.53)	MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL20516492	0.88	MDK (0.53)	MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL31067715	0.88	MDK (0.53)	MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL31067693	0.88	MDK (0.53)	MAPK1LGALS3LGALS8LGALS4CD69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20250281590-A1	IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF	PFIZER (US)	2025-09-11	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20250281590-A1	IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF	C5AR1, C3AR1, C5	MAPK1 3407/4885LGALS3 128/4885LGALS8 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.